colonoscopy preparation.
Conditions
Interventions
Intervention 1: Control group: In this study, all patients will undergo colonoscopy in the afternoon and we will use a split-dose preparation, i.e., administering half of the colon cleansing agent in
Sponsors
Shahid Beheshti University of Medical Sciences
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: People more than 18 year-old. Giving a written consent. Indications for colorectal cancer screening, include: average-risk screening, increased-risk screening (patients with one or more first degree relative[s] with colorectal cancer [CRC] or colorectal adenomas, hereditary CRC syndromes), positive fecal occult blood test, documented iron deficiency anemia in men or postmenopausal women. Lower gastrointestinal symptoms such as unexplained chronic clinically significant diarrhea, or unexplained involuntary weight loss. Abnormal abdominal imaging such as abnormalities detected on barium enema, abdominal computed tomography and etc.
Exclusion criteria
Exclusion criteria: Hypersensitivity to polyethylene glycol or senna Taking laxatives within one week prior to colonoscopy Previous colonic resection surgery Known or suspected bowel obstruction Prior history of colonoscopy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of colon preparation. Timepoint: During colonoscopy (within first 24 hours after use regimens). Method of measurement: Endoscopist report based on BBPS (Boston Bowel Preparation Scale). | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse effects of preparation regimens. Timepoint: While taking the drug until colonoscopy. Method of measurement: patients report. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohsen Rajabnia
Shahid Beheshti University of Medical Sciences
Outcome results
None listed